|
"yen c j"的相關文件
顯示項目 321-370 / 471 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2020-03-27T02:03:30Z |
High peritoneal KT/V and peritonitis rates are associated with peritoneal calcification.
|
Lee J.K.; Wu H.Y.; Chiang C.K.; Cheng H.T.; Yen C.J.; Hung K.Y.; Wu C.K.; Fang C.C.; KAO-LANG LIU; Yang C.Y.; Lien Y.C.; Huang J.W.; Huang J.W.;Lien Y.C.;Yang C.Y.;Kao-Lang Liu;Fang C.C.;Wu C.K.;Lee J.K.;Wu H.Y.;Chiang C.K.;Cheng H.T.;Yen C.J.;Hung K.Y. |
| 臺大學術典藏 |
2020-03-27T02:03:28Z |
Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis
|
Hung K.-Y.; Huang J.-W.;Lien Y.-C.;Yang C.-Y.;Kao-Lang Liu;Wu C.-F.;Yen C.-J.;Wu C.-K.;Lee J.-K.;Ho S.-R.;Wu H.-Y.;Chiang C.-K.;Cheng H.-T.;Shyu R.-S.;Hung K.-Y.; Huang J.-W.; Lien Y.-C.; Yang C.-Y.; KAO-LANG LIU; Wu C.-F.; Yen C.-J.; Wu C.-K.; Lee J.-K.; Ho S.-R.; Wu H.-Y.; Chiang C.-K.; Cheng H.-T.; Shyu R.-S. |
| 臺大學術典藏 |
2020-03-24T07:38:18Z |
Effect of intraperitoneally administered agents on human peritoneal mesothelial cell growth
|
Tsai T.-J.;Yen C.-J.;Cheng-Chung Fang;Yang C.-C.;Lee P.-H.;Yen T.-S.; Yen T.-S.; Yang C.-C.; Lee P.-H.; CHENG-CHUNG FANG; Tsai T.-J.; Yen C.-J. |
| 臺大學術典藏 |
2020-03-24T07:38:17Z |
Extracellular matrix proteins modulate human peritoneal mesothelial cell behavior
|
Tsai T.-J.; Lee P.-H.; Wu K.-D.; Yen C.-J.;Cheng-Chung Fang;Chen Y.-M.;Lin R.-H.;Wu K.-D.;Lee P.-H.;Tsai T.-J.; Yen C.-J.; CHENG-CHUNG FANG; Chen Y.-M.; Lin R.-H. |
| 臺大學術典藏 |
2020-03-24T07:38:17Z |
Hydralazine inhibits human peritoneal mesothelial cell proliferation and collagen synthesis
|
CHENG-CHUNG FANG; Yen C.-J.; Chen Y.-M.; Ko F.-N.; Tsai T.-J.; Lee P.-H.; Hsieh B.-S.; Cheng-Chung Fang;Yen C.-J.;Chen Y.-M.;Ko F.-N.;Tsai T.-J.;Lee P.-H.;Hsieh B.-S. |
| 臺大學術典藏 |
2020-03-24T07:38:17Z |
Effects of Intraperitoneal Antibiotics on Human Peritoneal Mesothelial Cell Growth
|
Yen T.-S.; Tsai K.-S.; Hung K.-Y.; Lee P.-H.; Lin R.-H.; Yang C.-C.; CHENG-CHUNG FANG; Chen H.-S.; Tsai T.-J.; Yen C.-J.; Yen C.-J.;Tsai T.-J.;Chen H.-S.;Cheng-Chung Fang;Yang C.-C.;Lee P.-H.;Lin R.-H.;Tsai K.-S.;Hung K.-Y.;Yen T.-S. |
| 臺大學術典藏 |
2020-03-24T07:38:16Z |
Pentoxifylline inhibits human peritoneal mesothelial cell growth and collagen synthesis: Effects on TGF-�]
|
Cheng-Chung Fang;Yen C.-J.;Chen Y.-M.;Shyu R.-S.;Tsai T.-J.;Lee P.-H.;Hsieh B.-S.; CHENG-CHUNG FANG; Yen C.-J.; Chen Y.-M.; Shyu R.-S.; Tsai T.-J.; Lee P.-H.; Hsieh B.-S. |
| 臺大學術典藏 |
2020-03-24T07:38:06Z |
Diltiazem suppresses collagen synthesis and IL-1�]-induced TGF-�]1 production on human peritoneal mesothelial cells
|
Tsai T.-J.;Yang J.-Y.;Lin M.-T.;Chu T.-S.;Chen Y.-M.;Yen C.-J.;CHENG-CHUNG FANG; CHENG-CHUNG FANG; Yen C.-J.; Chen Y.-M.; Chu T.-S.; Lin M.-T.; Yang J.-Y.; Tsai T.-J. |
| 臺大學術典藏 |
2020-03-24T07:38:00Z |
Fibrin-Induced Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelial Cells as a Mechanism of Peritoneal Fibrosis: Effects of Pentoxifylline
|
Cheng-Chung Fang;Huang J.-W.;Shyu R.-S.;Yen C.-J.;Shiao C.-H.;Chiang C.-K.;Hu R.-H.;Tsai T.-J.; CHENG-CHUNG FANG; Huang J.-W.; Shyu R.-S.; Yen C.-J.; Shiao C.-H.; Chiang C.-K.; Hu R.-H.; Tsai T.-J. |
| 臺大學術典藏 |
2020-03-24T07:37:59Z |
Peritoneal dialysis peritonitis by anaerobic pathogens: A retrospective case series
|
Chao C.-T.; Lee S.-Y.; Yang W.-S.; Chen H.-W.; CHENG-CHUNG FANG; Yen C.-J.; Chiang C.-K.; Hung K.-Y.; Huang J.-W. |
| 臺大學術典藏 |
2020-03-24T07:37:57Z |
Sequence variants of peroxisome proliferator-activated receptor-gamma gene and the clinical courses of patients with end-stage renal disease
|
Chao C.-T.; Chen Y.-C.; Chiang C.-K.; Huang J.-W.; Hu F.-C.; CHENG-CHUNG FANG; Chang C.-C.; Yen C.-J. |
| 臺大學術典藏 |
2020-03-24T07:37:57Z |
Acinetobacter peritoneal dialysis peritonitis: A changing landscape over time
|
Huang J.-W.; Hung K.-Y.; Chiang C.-K.; Yen C.-J.; Chao C.-T.; Lee S.-Y.; Yang W.-S.; Chen H.-W.; CHENG-CHUNG FANG |
| 臺大學術典藏 |
2020-03-24T07:37:55Z |
Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin
|
Yen C.-J.; Chang C.-C.; Hu F.-C.; CHENG-CHUNG FANG; Chen Y.-C.; Chiang C.-K.; Huang J.-W.; Chao C.-T. |
| 臺大學術典藏 |
2020-03-23T04:01:07Z |
Diltiazem suppresses collagen synthesis and IL-1β-induced TGF-β1 production on human peritoneal mesothelial cells
|
Fang C.-C.;Yen C.-J.;Chen Y.-M.;Chu T.-S.;Ming-Tsan Lin;Yang J.-Y.;Tsai T.-J.; Fang C.-C.; Yen C.-J.; Chen Y.-M.; Chu T.-S.; MING-TSAN LIN; Yang J.-Y.; Tsai T.-J. |
| 臺大學術典藏 |
2020-03-05T05:37:47Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen C.-H.; Chen Y.-F.; Chiu M.-J.; Chen T.-F.; Tsai P.-H.; Chen J.-H.; Yen C.-J.; Tang S.-C.; SHIN-JOE YEH; Chen Y.-C. |
| 臺大學術典藏 |
2020-03-04T05:42:41Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen C.-H; Chen Y.-F; Chiu M.-J; Chen T.-F; Tsai P.-H; Chen J.-H; Yen C.-J; SUNG-CHUN TANG; Yeh S.-J; Chen Y.-C. |
| 臺大學術典藏 |
2020-03-04T05:34:53Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen C.-H.; Chen Y.-F.; MING-JANG CHIU; Chen T.-F.; Tsai P.-H.; Chen J.-H.; Yen C.-J.; Tang S.-C.; Yeh S.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2020-03-03T01:14:40Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen C.-H; Chen Y.-F; Chiu M.-J; TA-FU CHEN; Tsai P.-H; Chen J.-H; Yen C.-J; Tang S.-C; Yeh S.-J; Chen Y.-C. |
| 臺大學術典藏 |
2020-03-02T12:10:52Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen C.-H; Chen Y.-F; Chiu M.-J; Chen T.-F; Tsai P.-H; Chen J.-H; Yen C.-J; SUNG-CHUN TANG; Yeh S.-J; Chen Y.-C. |
| 臺大學術典藏 |
2020-03-02T03:10:58Z |
Genome-wide association study for autism spectrum disorder in taiwanese han population
|
Kuo P.-H.; Chuang L.-C.; Su M.-H.; Chen C.-H.; Wu J.-Y.; Yen C.-J.; Wu Y.-Y.; Liu S.-K.; Chou M.-C.; Chou W.-J.; Chiu Y.-N.; Tsai W.-C.; SUSAN SHUR-FEN GAU; Esteban F.J. |
| 臺大學術典藏 |
2020-02-27T07:43:40Z |
Seasonal effects on cardiovascular mortality in older patients [6]
|
Yen C.-J.; Lee Y.-T.;Liau C.-S.;WEN-JONE CHEN;Sung F.-C.;Chao C.-L.;Yen C.-J.; Chao C.-L.; Sung F.-C.; WEN-JONE CHEN; Liau C.-S.; Lee Y.-T. |
| 臺大學術典藏 |
2020-02-20T06:53:14Z |
Modified hospital elder life program: Effects on abdominal surgery patients
|
Chen C.C.-H.;Lin M.-T.;Yu-Wen Tien;Yen C.-J.;Huang G.-H.;Inouye S.K.; Chen C.C.-H.; Lin M.-T.; YU-WEN TIEN; Yen C.-J.; Huang G.-H.; Inouye S.K. |
| 臺大學術典藏 |
2020-02-20T02:56:54Z |
Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma
|
Chen H.-A.; Kuo T.-C.; Tseng C.-F.; Ma J.-T.; Yang S.-T.; Yen C.-J.; CHING-YAO YANG; Sung S.-Y.; Su J.-L. |
| 臺大學術典藏 |
2020 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Douillard J.-Y.; Yoshino T.; CHIH-HUNG HSU; Yen Y.; Tabernero J.; Shen Y.-C.; Hsu C.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Yen C.-J.; Huang Y.-H.; Chen S.-C.; Cheng A.-L.; Martinelli E.; Chen L.-T.; Chen L.-T.;Martinelli E.;Cheng A.-L.;Pentheroudakis G.;Qin S.;Bhattacharyya G.S.;Ikeda M.;Lim H.-Y.;Ho G.F.;Choo S.P.;Ren Z.;Malhotra H.;Ueno M.;Ryoo B.-Y.;Kiang T.C.;Tai D.;Vogel A.;Cervantes A.;Lu S.-N.;Yen C.-J.;Huang Y.-H.;Chen S.-C.;Hsu C.;Shen Y.-C.;Tabernero J.;Yen Y.;Chih-Hung Hsu;Yoshino T.;Douillard J.-Y.; Choo S.P.; Ho G.F.; Lim H.-Y.; Ikeda M.; Bhattacharyya G.S.; Qin S.; Pentheroudakis G. |
| 臺大學術典藏 |
2020 |
Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training program
|
Yen C.-J.; Sheng W.-H.; Tsai S.-L.; Chu T.-S.; Ko B.-S.; Lin L.-C.; Tseng F.-Y.; Chang C.-H.; Wu C.-H.; Shih S.-R.; Chiu W.-Y.; Pan S.-C.; Chen W.-P.; PO-YUAN CHANG |
| 臺大學術典藏 |
2020 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.; Tsou H.-H.; CHIUN HSU; Yen C.-J.; Yang S.-H.; Chen M.-H.; Chiang N.-J. |
| 國立成功大學 |
2020 |
Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan
|
Shan, Y.-S.;Chen, L.-T.;Wu, J.-S.;Chang, Y.-F.;Lee, C.-T.;Wu, C.-H.;Chiang, N.-J.;Huang, Huang H.-E.;Yen, C.-J.;Chao, Y.-J.;Tsai, H.-J.;Chen, Chen C.-Y.;Kang, J.-W.;Kuo, C.-F.;Tsai, C.-R.;Weng, Y.-L.;Yang, H.-C.;Liu, H.-C.;Chang, J.S. |
| 國立成功大學 |
2020 |
Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141)
|
Yen, C.-J.;Kiyota, N.;Hanai, N.;Takahashi, S.;Yokota, T.;Iwae, S.;Shimizu, Y.;Hong, R.-L.;Goto, M.;Kang, J.-H.;Li, W.S.K.;Ferris, R.L.;Gillison, M.;Endo, T.;Jayaprakash, V.;Tahara, M. |
| 國立成功大學 |
2020 |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
de, Bono J.;Lin, C.-C.;Chen, L.-T.;Corral, J.;Michalarea, V.;Rihawi, K.;Ong, M.;Lee, J.-H.;Hsu, C.-H.;Yang, J.C.-H.;Shiah, H.-S.;Yen, C.-J.;Anthoney, Anthoney A.;Jove, M.;Buschke, S.;Fuertig, R.;Schmid, U.;Goeldner, R.-G.;Strelkowa, N.;Huang, D.C.-L.;Bogenrieder, T.;Twelves, C.;Cheng, A.-L. |
| 國立成功大學 |
2020 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen, L.-T.;Martinelli, E.;Cheng, A.-L.;Pentheroudakis, G.;Qin, S.;Bhattacharyya, G.S.;Ikeda, M.;Lim, H.-Y.;Ho, G.F.;Choo, S.P.;Ren, Z.;Malhotra, H.;Ueno, M.;Ryoo, B.-Y.;Kiang, T.C.;Tai, D.;Vogel, A.;Cervantes, A.;Lu, S.-N.;Yen, C.-J.;Huang, Y.-H.;Chen, S.-C.;Hsu, C.;Shen, Y.-C.;Tabernero, J.;Yen, Yen Y.;Hsu, C.-H.;Yoshino, T.;Douillard, J.-Y. |
| 國立成功大學 |
2020 |
Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies
|
Yen, C.-J.;Kudo, M.;Lim, H.-Y.;Hsu, C.-H.;Vogel, A.;Brandi, G.;Cheng, R.;Nitu, I.S.;Abada, P.;Hsu, Y.;Zhu, A.X.;Kang, Y.-K. |
| 國立成功大學 |
2020 |
A selective Aurora-A 5′-UTR siRNA inhibits tumor growth and metastasis
|
Lai, C.-H.;Chen, R.-Y.;Hsieh, Hsieh H.-P.;Tsai, S.-J.;Chang, K.-C.;Yen, C.-J.;Huang, Y.-C.;Liu, Y.-W.;Lee, J.-C.;Lai, Y.-C.;Hung, L.-Y.;Lin, B.-W. |
| 國立成功大學 |
2020 |
Investigating the health disparities in the association between lifestyle behaviors and the risk of head and neck cancer
|
Hsiao, J.-R.;Huang, C.-C.;Ou, C.-Y.;Chang, Chang C.-C.;Lee, W.-T.;Tsai, S.-T.;Huang, J.-S.;Chen, K.-C.;Lai, Y.-H.;Wu, Y.-H.;Hsueh, W.-T.;Wu, S.-Y.;Yen, C.-J.;Chang, J.-Y.;Lin, C.-L.;Weng, Y.-L.;Yang, H.-C.;Chen, Y.-S.;Chang, J.S. |
| 國立成功大學 |
2020 |
Satisfaction with pain management and impact of pain on quality of life in cancer patients
|
Lin, J.;Hsieh, R.-K.;Chen, J.-S.;Lee, K.-D.;Rau, K.-M.;Shao, Y.-Y.;Sung, Y.-C.;Yeh, S.-P.;Chang, Chang C.-S.;Liu, T.-C.;Wu, M.-F.;Lee, M.-Y.;Yu, M.-S.;Yen, C.-J.;Lai, P.-Y.;Hwang, W.-L.;Chiou, T.-J. |
| 國立成功大學 |
2020 |
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors
|
Desai, J.;Deva, S.;Lee, J.S.;Lin, C.-C.;Yen, C.-J.;Chao, Y.;Keam, B.;Jameson, M.;Hou, M.-M.;Kang, Y.-K.;Markman, B.;Lu, C.-H.;Rau, K.-M.;Lee, K.-H.;Horvath, L.;Friedlander, M.;Hill, A.;Sandhu, Sandhu S.;Barlow, P.;Wu, C.-Y.;Zhang, Y.;Liang, Liang L.;Wu, J.;Paton, V.;Millward, Millward M. |
| 國立成功大學 |
2020 |
Phase I dose-escalation and -expansion study of telisotuzumab (ABT-700), an Anti-c-met antibody, in patients with advanced solid tumors
|
Strickler, J.H.;LoRusso, P.;Salgia, R.;Kang, Y.-K.;Yen, C.J.;Lin, C.-C.;Ansell, P.;Motwani, Motwani M.;Wong, S.;Yue, H.;Wang, L.;Reilly, E.;Afar, D.;Naumovski, L.;Ramanathan, Ramanathan R.K. |
| 國立成功大學 |
2020 |
Safety and Preliminary Efficacy of Ramucirumab in Combination with FOLFOX4 in Patients with Advanced Hepatocellular Carcinoma: A Nonrandomized, Open-Label, Phase Ib Study
|
Lin, C.-C.;Yang, T.-S.;Yen, C.-J.;Cheng, R.;Liu, J.;Hsu, C. |
| 國立成功大學 |
2020 |
Dishevelled 1-Regulated Superpotent Cancer Stem Cells Mediate Wnt Heterogeneity and Tumor Progression in Hepatocellular Carcinoma
|
Liao, W.-Y.;Hsu, C.-C.;Chan, T.-S.;Yen, C.-J.;Chen, W.-Y.;Pan, H.-W.;Tsai, K.K. |
| 國立成功大學 |
2020 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang, N.-J.;Chen, M.-H.;Yang, S.-H.;Hsu, C.;Yen, C.-J.;Tsou, H.-H.;Su, Y.-Y.;Chen, J.-S.;Shan, Y.-S.;Chen, L.-T. |
| 臺大學術典藏 |
2019 |
Old age is a positive modifier of renal outcome in Taiwanese patients with stages 3-5 chronic kidney disease
|
Chou Y.-H.;Yen C.-J.;Lai T.-S.;Yung-Ming Chen; Chou Y.-H.; Yen C.-J.; Lai T.-S.; YUNG-MING CHEN |
| 臺大學術典藏 |
2019 |
Old age is a positive modifier of renal outcome in Taiwanese patients with stages 3–5 chronic kidney disease
|
Chen Y.-M.; TAI-SHUAN LAI; Chou Y.-H.; Yen C.-J. |
| 臺大學術典藏 |
2019 |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; CHIUN HSU; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L. |
| 國立成功大學 |
2019 |
Effect of First-line S-1 Plus Oxaliplatin with or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial
|
Yoshikawa, T.;Muro, K.;Shitara, K.;Oh, D.-Y.;Kang, Y.-K.;Chung, H.C.;Kudo, T.;Chin, K.;Kadowaki, S.;Hamamoto, Y.;Hironaka, S.;Yoshida, K.;Yen, C.-J.;Omuro, Y.;Bai, L.-Y.;Maeda, K.;Ozeki, A.;Yoshikawa, R.;Kitagawa, Y. |
| 國立成功大學 |
2019 |
Oral hygiene and the overall survival of head and neck cancer patients
|
Chang, Chang C.-C.;Lee, W.-T.;Hsiao, J.-R.;Ou, C.-Y.;Huang, C.-C.;Tsai, S.-T.;Chen, K.-C.;Huang, J.-S.;Wong, T.-Y.;Lai, Y.-H.;Wu, Y.-H.;Hsueh, W.-T.;Wu, S.-Y.;Yen, C.-J.;Chang, J.-Y.;Lin, C.-L.;Weng, Y.-L.;Yang, H.-C.;Chen, Y.-S.;Chang, J.S. |
| 國立成功大學 |
2019 |
A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life
|
Chou, W.-C.;Chen, J.-S.;Hung, C.-Y.;Lu, C.-H.;Shao, Y.-Y.;Chiou, T.-J.;Sung, Y.-C.;Rau, K.-M.;Yen, C.-J.;Yeh, S.-P.;Liu, T.-C.;Wu, M.-F.;Lee, M.-Y.;Yu, M.-S.;Hwang, W.-L.;Lai, P.-Y.;Chang, Chang C.-S.;Hsieh, R.-K. |
| 國立成功大學 |
2019 |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu, Lu L.-C.;Hsu, C.;Shao, Y.-Y.;Chao, Y.;Yen, C.-J.;Shih, I.-L.;Hung, Y.-P.;Chang, Chang C.-J.;Shen, Y.-C.;Guo, J.-C.;Liu, T.-H.;Hsu, C.-H.;Cheng, A.-L. |
| 國立成功大學 |
2019 |
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
|
Qin, S.;Chan, S.L.;Sukeepaisarnjaroen, W.;Han, G.;Choo, S.P.;Sriuranpong, V.;Pan, H.;Yau, T.;Guo, Y.;Chen, M.;Ren, Z.;Xu, J.;Yen, C.-J.;Lin, Z.-Z.;Manenti, L.;Gu, Y.;Sun, Y.;Tiedt, R.;Hao, L.;Song, W.;Tanwandee, Tanwandee T. |
| 國立成功大學 |
2019 |
Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study
|
Cho, S.-F.;Rau, K.-M.;Shao, Y.-Y.;Yen, C.-J.;Wu, M.-F.;Chen, J.-S.;Chang, Chang C.-S.;Yeh, S.-P.;Chiou, T.-J.;Hsieh, R.-K.;Lee, M.-Y.;Sung, Y.-C.;Lee, K.-D.;Lai, P.-Y.;Yu, M.-S.;Hwang, W.-L.;Liu, T.-C. |
| 國立成功大學 |
2019 |
Generation of a heterozygous p53 R249S mutant human embryonic stem cell line by TALEN-mediated genome editing
|
Huo, Z.;Tu, J.;Xu, A.;Li, Y.;Wang, D.;Liu, M.;Zhou, R.;Zhu, D.;Lin, Y.;Gingold, J.A.;Yen, C.-J.;Xiao, H.;Zhao, R. |
| 國立成功大學 |
2019 |
The influence of prediagnosis alcohol consumption and the polymorphisms of ethanol-metabolizing genes on the survival of head and neck cancer patients
|
Lee, W.-T.;Hsiao, J.-R.;Ou, C.-Y.;Huang, C.-C.;Chang, Chang C.-C.;Tsai, S.-T.;Chen, K.-C.;Huang, J.-S.;Wong, T.-Y.;Lai, Y.-H.;Wu, Y.-H.;Hsueh, W.-T.;Wu, S.-Y.;Yen, C.-J.;Chang, J.-Y.;Lin, C.-L.;Weng, Y.-L.;Yang, H.-C.;Chen, Y.-S.;Chang, J.S. |
顯示項目 321-370 / 471 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
